Marks R, Motley RJ. Skin cancer. Recognition and treatment. Drugs. 1995 Jul;50(1):48-61.
Shah JP, Gil Z. Current concepts in management of oral cancer-surgery. Oral Oncol. 2009 Apr-May;45(4-5):394-401.
Calitchi E, Kirova Y, Le Bourgeois JP. [Radiotherapy and skin tumors]. Cancer Radiother. 1998 Sep-Oct;2(5):556-65.
Kirova YM, Feuilhade F, Calitchi E, Otmezguine Y, Belembaogo E, Le Bourgeois JP. [Radiation-induced sarcoma after breast cancer. Apropos of 8 cases and review of the literature]. Cancer Radiother. 1998 Jul-Aug;2(4):381-6. (Pubitemid 28419420)
Kirova YM, Belembaogo E, Frikha H, Haddad E, Calitchi E, Levy E, et al. Radiotherapy in the management of epidemic Kaposi's sarcoma: a retrospective study of 643 cases. Radiother Oncol. 1998 Jan;46(1):19-22. (Pubitemid 28072853)
Yamamoto N, Ikeda C, Yakushiji T, Nomura T, Katakura A, Shibahara T, et al. Genetic effects of X-ray and carbon ion irradiation in head and neck carcinoma cell lines. Bull Tokyo Dent Coll. 2007 Nov;48(4):177-85.
Tapajos EC, Longo JP, Simioni AR, Lacava ZG, Santos MF, Morais PC, et al. In vitro photodynamic therapy on human oral keratinocytes using chloroaluminum-phthalocyanine. Oral Oncol. 2008 Nov;44(11):1073-9.
Pusapati RV, Weaks RL, Rounbehler RJ, McArthur MJ, Johnson DG. E2F2 suppresses Myc-induced proliferation and tumorigenesis. Mol Carcinog. 2009 Oct 1.
Menendez D, Inga A, Resnick M.A. The expanding universe of p53 targets. Nat Rev Cancer. 2009 Oct;9(10):724-37.
Shyr CR, Tsai MY, Yeh S, Kang HY, Chang YC, Wong PL, et al. Tumor suppressor PAX6 functions as androgen receptor Co-repressor to inhibit prostate cancer growth. Prostate. 2009 Sep 29;in press.
Singh S, Narang AS, Mahato RI. Subcellular Fate and Off-Target Effects of siRNA, shRNA, and miRNA. Pharm Res. 2011 Oct 28.
Olejniczak M, Polak K, Galka-Marciniak P, Krzyzosiak WJ. Recent Advances in Understanding of the Immunological Off-target Effects of siRNA. Curr Gene Ther. 2011 Oct 21;11(6).
Shieh JJ, Liu KT, Huang SW, Chen YJ, Hsieh TY. Modification of alternative splicing of Mcl-1 pre-mRNA using antisense morpholino oligonucleotides induces apoptosis in basal cell carcinoma cells. J Invest Dermatol. 2009 Oct;129(10):2497-506.
Ji J, Wernli M, Buechner S, Erb P. Fas ligand downregulation with antisense oligonucleotides in cells and in cultured tissues of normal skin epidermis and basal cell carcinoM.A. J Invest Dermatol. 2003 Jun;120(6):1094-9. (Pubitemid 36702923)
Heemskerk H, de Winter CL, van Ommen GJ, van Deutekom JC, Aartsma-Rus A. Development of antisense-mediated exon skipping as a treatment for duchenne muscular dystrophy. Ann N Y Acad Sci. 2009 Sep;1175:71-9.
Akhtar S, Hughes MD, Khan A, Bibby M, Hussain M, Nawaz Q, et al. The delivery of antisense therapeutics. Adv Drug Deliv Rev. 2000 Oct 31;44(1):3-21.
Furukawa J, Wraight CJ, Freier SM, Peralta E, Atley LM, Monia BP, et al. Antisense oligonucleotide targeting of insulin-like growth factor-1 receptor (IGF-1R) in prostate cancer. Prostate. 2010 Feb 1;70(2):206-18.
Tseng JC, Granot T, Digiacomo V, Levin B, Meruelo D. Enhanced specific delivery and targeting of oncolytic Sindbis viral vectors by modulating vascular leakiness in tumor. Cancer Gene Ther. 2009 Oct 2;in press.
Thacker EE, Nakayama M, Smith BF, Bird RC, Muminova Z, Strong TV, et al. A genetically engineered adenovirus vector targeted to CD40 mediates transduction of canine dendritic cells and promotes antigen-specific immune responses in vivo. Vaccine. 2009 Nov 23;27(50):7116-24.
Huang M, Chen Z, Hu S, Jia F, Li Z, Hoyt G, et al. Novel minicircle vector for gene therapy in murine myocardial infarction. Circulation. 2009 Sep 15;120(11 Suppl):S230-7.
Thomas CE, Ehrhardt A, Kay M.A. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet. 2003 May;4(5):346-58. (Pubitemid 36538359)
Farrell LL, Pepin J, Kucharski C, Lin X, Xu Z, Uludag H. A comparison of the effectiveness of cationic polymers poly-L-lysine (PLL) and polyethylenimine (PEI) for non-viral delivery of plasmid DNA to bone marrow stromal cells (BMSC). Eur J Pharm Biopharm. 2007 Mar;65(3):388-97.
Morille M, Passirani C, Vonarbourg A, Clavreul A, Benoit JP. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials. 2008 Aug-Sep;29(24-25): 3477-96.
van de Wetering P, Cherng JY, Talsma H, Crommelin DJ, Hennink WE. 2-(Dimethylamino)ethyl methacrylate based (co)polymers as gene transfer agents. J Control Release. 1998 Apr 30;53 (1-3):145-53. (Pubitemid 28219308)
van der Aa MA, Huth US, Hafele SY, Schubert R, Oosting RS, Mastrobattista E, et al. Cellular uptake of cationic polymer-DNA complexes via caveolae plays a pivotal role in gene transfection in COS-7 cells. Pharm Res. 2007 Aug;24(8):1590-8. (Pubitemid 46988225)
Labas R, Beilvert F, Barteau B, David S, Chevre R, Pitard B. Nature as a source of inspiration for cationic lipid synthesis. Genetica. 2010 Feb;138(2):153-68.
Noguchi A, Furuno T, Kawaura C, Nakanishi M. Membrane fusion plays an important role in gene transfection mediated by cationic liposomes. FEBS Lett. 1998 Aug 14;433(1-2):169-73. (Pubitemid 28386752)
Fletcher S, Ahmad A, Perouzel E, Jorgensen MR, Miller AD. A dialkynoyl analogue of DOPE improves gene transfer of lowercharged, cationic lipoplexes. Org Biomol Chem. 2006 Jan 21;4(2):196-9.
Boussif O, Gaucheron J, Boulanger C, Santaella C, Kolbe HV, Vierling P. Enhanced in vitro and in vivo cationic lipid-mediated gene delivery with a fluorinated glycerophosphoethanolamine helper lipid. J Gene Med. 2001 Mar-Apr;3(2):109-14. (Pubitemid 33685437)
Gaucheron J, Boulanger C, Santaella C, Sbirrazzuoli N, Boussif O, Vierling P. In vitro cationic lipid-mediated gene delivery with fluorinated glycerophosphoethanolamine helper lipids. Bioconjug Chem. 2001 Nov-Dec;12(6):949-63. (Pubitemid 33136865)
Mukherjee AK, Ghosal SK, Maity CR. Lysosomal membrane stabilization by alpha-tocopherol against the damaging action of Vipera russelli venom phospholipase A2. Cell Mol Life Sci. 1997 Feb;53(2):152-5. (Pubitemid 27365886)
Sonawane ND, Szoka FC, Jr., Verkman AS. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J Biol Chem. 2003 Nov 7;278(45):44826-31. (Pubitemid 37377241)
Funhoff AM, van Nostrum CF, Koning GA, Schuurmans-Nieuwenbroek NM, Crommelin DJ, Hennink WE. Endosomal escape of polymeric gene delivery complexes is not always enhanced by polymers buffering at low pH. Biomacromolecules. 2004 Jan-Feb;5(1):32-9. (Pubitemid 38181309)
Van Overstraeten-Schlogel N, Ho-Shim Y, Tevel V, Bontems S, Dubois P, Raes M. Transfection of Immortalized Keratinocytes by Low Toxic Poly(2-(Dimethylamino)Ethyl Methacrylate)-Based Polymers. J Biomater Sci Polym Ed. 2011 Mar 10.
Shim Y.-H. BF, Coulember O., Lazzaroni R., Dubois P.. Synthesis and characterization of original 2-(dimethylamino)ethylmethacrylate/ poly(ethyleneglycol) star-copolymers. Eur Polym J 2008;44.
Kitsera N, Khobta A, Epe B. Destabilized green fluorescent protein detects rapid removal of transcription blocks after genotoxic exposure. Biotechniques. 2007 Aug;43(2):222-7. (Pubitemid 47255056)
Wolfert MA, Dash PR, Nazarova O, Oupicky D, Seymour LW, Smart S, et al. Polyelectrolyte vectors for gene delivery: influence of cationic polymer on biophysical properties of complexes formed with DNA. Bioconjug Chem. 1999 Nov-Dec;10(6):993-1004.
Verbaan FJ, Klein Klouwenberg P, van Steenis JH, Snel CJ, Boerman O, Hennink WE, et al. Application of poly(2-(dimethylamino) ethyl methacrylate)-based polyplexes for gene transfer into human ovarian carcinoma cells. Int J Pharm. 2005 Nov 4;304(1-2): 185-92. (Pubitemid 41427661)
Brunner S, Sauer T, Carotta S, Cotten M, Saltik M, Wagner E. Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus. Gene Ther. 2000 Mar;7(5):401-7. (Pubitemid 30156552)
Mortimer I, Tam P, MacLachlan I, Graham RW, Saravolac EG, Joshi PB. Cationic lipid-mediated transfection of cells in culture requires mitotic activity. Gene Ther. 1999 Mar;6(3):403-11. (Pubitemid 29132342)
Dehshahri A, Oskuee RK, Shier WT, Hatefi A, Ramezani M. Gene transfer efficiency of high primary amine content, hydrophobic, alkyl-oligoamine derivatives of polyethylenimine. Biomaterials. 2009 Sep;30(25):4187-94.
Liu M, Chen J, Cheng YP, Xue YN, Zhuo RX, Huang SW. Novel poly(amidoamine)s with pendant primary amines as highly efficient gene delivery vectors. Macromol Biosci. 2010 Apr 8;10(4):384-92.
Creusat G, Rinaldi AS, Weiss E, Elbaghdadi R, Remy JS, Mulherkar R, et al. Proton sponge trick for pH-sensitive disassembly of polyethylenimine-based siRNA delivery systems. Bioconjug Chem. 2010 May 19;21(5):994-1002.
Agarwal A, Unfer R, Mallapragada SK. Novel cationic pentablock copolymers as non-viral vectors for gene therapy. J Control Release. 2005 Mar 2;103(1):245-58. (Pubitemid 40248576)
